The essential oil from leaves of Zhumeria majdae Rech. (ZMEO), had been shown to have several beneficial effects in clinic. Here, we examined anticonvulsant activities of ZMEO in experimental mouse model of seizure and tried to identify possible underlying mechanisms. ZMEO (5, 10, 20 and 40 mg kg-1, IP) or diazepam, as reference anti-convulsant drug (25, 50 and 100 µg kg-1, IP), were administered 60 min prior to PTZ injection (IV or IP) and changes in threshold, latency and frequency of clonic seizure were examined. I.P PTZ induced model of seizure was also applied for examining protective effects of ZMEO pretreatment against PTZ induced mortality. In some studies, the anti-convulsant effect of the combination of diazepam and ZMEO was also studied. Protective effects of ZMEO against hind-limb tonic extensions (HLTE) was also examined by maximal electroshock (MES) seizure test. The GABAergic mechanism, as well as NO pathway involvement in anticonvulsant activity of ZMEO were assessed by pretreating animals with Flumazenil, L-NAME, Aminoguanidine and L-Arginine in PTZ induced model of seizure. Administration of 20 mg/kg ZMEO could significantly increase chronic seizure threshold and latency while reducing frequency of convulsions and mortality in the PTZ-induced model. In studied doses, ZMEO could not protect mice from HLTE and mortality induced by MES. Pretreatment with L-arginine and diazepam potentiated anticonvulsant effects of ZMEO while pretreatment with L-NAME, Aminoguanidine and flumazenil reversed anticonvulsant activity. In conclusion, recorded anticonvulsant activity of ZMEO may be mediated in part through GABAergic mechanism and NO signaling pathway.
40 ml/kg, IP), diazepam (25, 50 or 100 µg kg −1 , IP) or vehicle (sweet almond oil; 10 mg kg −1 IP) 60 min prior to IV infusion of PTZ (0.5% PTZ solution, 0.5 ml/min). Infusion was halted when full clonus of the body was spotted. This usually takes place soon after initiation of forelimb clonus (Fig. 1A) 20 . At this point, the total amount of delivered PTZ per 1-kilogram body weight of each mouse was calculated according to the following formula and referred as clonic seizure threshold: combination of diazepam and ZMEO was studied, diazepam and ZMEO were administered 5 and 15 min after injection of flumazenil respectively. After 60 min, mice were infused at a constant rate with PTZ (0.5 ml/min, 0.5%). Alteration in CST was recorded for each group separately and compared with each other (Fig. 1B) .
The possible role of NO pathway involvement in the anticonvulsant activity of ZMEO was examined by pretreating mice with sub-effective doses of L-arginine (30 mg kg −1 , IP), a precursor for nitric oxide synthesis; L-NAME (2.5 mg kg −1 , IP), a non-selective inhibitor of nitric oxide synthase (NOS); and aminoguanidine (100 mg kg −1 , IP), a selective inhibitor of inducible NOS (iNOS); 15 min prior to administration of ZMEO (10 and 20 mg kg −1 , IP). After 60 min, mice were infused with PTZ. Alteration in CST was then reported in response to pretreatment with modulators ( Fig. 1C ). Doses of pharmacological modulators were chosen according to the pilot experiments and similar studies in literature 21, 22 .
Intraperitoneal (IP) Pentylenetetrazol-induced seizures
Acute IP administration of PTZ (85 mg/kg) was used to evaluate the frequency and latency of generalized clonic seizure and the incidence of death. Mice were classified into 8 groups, each comprising of 8 mice, and received ZMEO (5, 10, 20 or 40 ml/kg, IP), diazepam (25, 50 or 100 µg kg −1 ,IP) or vehicle (sweet almond oil;
10 mg kg −1 IP) 60 min prior to IP infusion of PTZ, respectively ( Fig. 1D ). duration of monitoring following PTZ administration was limited to 30 min and a latency of 1800 sec was recorded for experiments in which no generalized seizure occurred 23 .
For examination of possible enrollment of GABA A receptor in protection induced by ZMEO in IP PTZ induced seizure model, flumazenil (0.5 mg/kg) or vehicle was administered 15 min prior to injection of ZMEO (20 mg Accepted Article kg -1 ) and diazepam (25 µg kg -1 ). In case where effect of flumazenil on combination of diazepam and ZMEO was studied, diazepam and ZMEO were administered 5 and 15 min after injection of flumazenil respectively.
After 60 min, mice were intraperitoneally injected with PTZ (85 mg/kg). Alteration in latency and frequency of clonic convulsions were then recorded for each group separately and compared with each other (Fig. 1E ).
Maximal electroshock seizure test
The seizures were induced by maximal electroshock (MES) in male NMRI mice with the help of an electroconvulsiometer by passing current of 35 mA, 50 Hz for 0.2 s using ear clip electrodes. Mice were classified in to 5 groups, each consisting of 10 mice. ZMEO (5, 20 and 40 mg/kg), phenytoin (25 mg/kg) or vehicle (sweet almond oil; 10 mg kg −1 , IP) were given 1 h prior to seizure induction. Drops of saline were instilled in both ears in order to ensure current transmission. The ability to reduce mortality and Incidence rate of tonic hind-limb extension (THLE) were used as end points for evaluating protective effects of ZMEO against MES induced seizure model 24, 25 .
Statistical analysis
Throughout the experiments, sample sizes of eight to ten (N = 8-10) were used. Clonic seizure's frequency, latency and threshold obtained from IP and IV PTZ induced models of seizure were expressed as mean ± 
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Chemical composition of ZMEO
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oil. Regarding the dominancy of Linalool and camphor in formulation, observed biological effects may be in large part attributed to the pharmacological activity of these two terpenes.
Effect of ZMEO on IP and IV Pentylenetetrazol-induced seizure models
Administration of ZMEO in IV PTZ induced seizure model resulted in a dose-dependent increase in clonic seizure threshold, with statistical significance beginning from 10 mg kg −1 (P<0.05), proposing protective effects of ZMEO against petit-mal clonic seizure (F 3, 28 = 79.87, P<0.0001; Fig. 3B ). Notably Contrarily, concurrent administration of 5 mg kg -1 ZMEO with 25 µg kg -1 diazepam could prevent from deaths induced by IP administration of PTZ in all mice (P=0.0003, χ2 (df=1) =13.39; Fig. 5b ).
Effect of ZMEO on maximal electroshock induced seizure model
Administration of electrical shock produced THLEs in almost all of the mice in vehicle receiving group ( Table   2 ). Administration of ZMEO at studied doses also did not produce any protective effects against THLEs.
Contrarily, administration of phenytoin with the dose of 25 mg kg −1 , could completely protect mice against THLEs and MES induced deaths.
GABA A receptor is partly involved in protective anti-convulsive effects of ZMEO
As depicted in Fig 5a pretreating mice with flumazenil ( Fig. 4b ). These results strongly suggest that GABA A receptors are at least partly involved in anticonvulsant activity observed with ZMEO.
NO pathway is partly involved in protective anti-convulsive effects of ZMEO
Lower row of Fig 
Discussion
Based on results obtained from GC-MS analysis, linalool and camphor were the main components of ZMEO.
Linalool is a tertiary alcohol belonging to acyclic monoterpenoid which is also a major floral scent found in nature. Several studies have reported potential inhibitory effect of linalool on neural excitability in variety of
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This article is protected by copyright. All rights reserved mice experimental models of seizure. For instance, administration of linalool has shown to delay onset of seizure in NMDA model or protect against picrotoxin, quinolinic acid, pentylenetetrazol and trans-corneal electroshock induced models of seizure 26 31 . In parallel, in sets of experiments other than epilepsy, the modulatory effects of ZMEO components on voltage-dependent Na + channels have also been established. For instance, the antinociceptive effects of linalool has shown to be stemmed from a decrease in voltage-dependent Na + current in neurons located at dorsal root ganglia, or terpinen-4-ol which has shown to be capable of decreasing Na + currents in electrophysiology studies 33 .
Today, MES and PTZ induced models of seizure are the most widely applied tests for preclinical examination of anticonvulsant activity of new investigational AEDs. In this context, MES is capable of identifying compounds with preventive effects against spreading of seizure, while PTZ mostly identifies agents with capability of rising seizure threshold 34, 35 .
Regardless of few exceptions, appropriately designed IP PTZ induced seizure model is a consistent model for human myoclonic jerks and spike-wave seizures. In this test, the suppressive effects of an investigational AED on clonic seizure induced by a proconvulsive IP dose of PTZ will be monitored. Therefore, the IP PTZ induced model of seizure is capable of only evaluating the ability of a compound to block a specific end point in a
This article is protected by copyright. All rights reserved quantal mode. In another words, It can only inform us whether a specific compound can prevent a seizure endpoint or not 36, 37 . Although recently, measurement of alterations in parameters including latency to onset, severity and duration of clonus seizure response, have been applied for quantifying responses in IP model, high
inter-animal variability in latency of seizure onset has significantly reduced precision of obtained results 38 .
Finally, evaluation of investigational AED's ability to improve survival may be effectively evaluated with this test 39 .
In contrast, IV PTZ induced model of seizure is widely applied to answer distinct question from those answered by IP PTZ induced seizure model. This model offers a very sensitive parametric approach for measuring seizure threshold 40 . In another words, instead of only identifying an agent with complete preventive effect on seizure occurrence, all agent capable of delaying its appearance can also be identified. Therefore, a quantifiable endpoint will be achieved by performing this test. Regarding the diversity of endpoints associated with each model, in present study both IP and IV PTZ induced models of seizure were used for acquiring a comprehensive data regarding the anticonvulsant activity of ZMEO. IP model was applied mainly for evaluating improvements in survival rate, latency to onset, severity and duration of clonus seizure response in ZMEO pretreated mice and IV PTZ induce model for measuring seizure susceptibility in each individual mouse.
Like other EOs, absorbed ZMEO in blood following IP administration will freely pass through blood brain barrier (BBB) to reach its site of action in CNS. This happens mainly owing to very small size (<400 Da) and
high lipid solubility of all components found in EOs 41, 42 . The dose-response curve obtained in IV PTZ induced seizure model of present study, didn't display the classic sigmoidal dose-response pattern. Instead, As depicted in Figure 3A both in rodents and humans [43] [44] [45] .
Indeed, this pro-convulsive activity observed with carbamazepine, phenytoin and herein ZMEO, may be attributed to the hyper-excitability of neuronal networks mediated by intensive activation of GABA A receptors at high administered doses of these agents. It has been shown that an intensive short term GABA 48 . In the case of ZMEO, consisting of 16 components, exploring the mechanism of this biphasic response may become somehow more complex. However, as stated above, one possible mechanism may be the activation or involvement of some receptors other than GABA A .
Flumazenil is a selective antagonist for benzodiazepine site on GABA A receptors which is mainly applied in clinic for reversing benzodiazepine overdose [49] [50] [51] . In research, flumazenil has been widely applied as a powerful tool for exploring benzodiazepine/ GABA A receptor interaction both in animals and humans with the purpose of searching endogenous or exogenous ligands for this receptor 52 . Based on obtained results, involvement of GABA A receptor was confirmed by three evidences: (1) As depicted in Fig. 5C , co-
administration of Diazepam and ZMEO both in their sub-effective concentrations induced protective effects in
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This article is protected by copyright. All rights reserved PTZ model. Therefore, two components must have an additive or synergistic effect together which could have antagonized the proconvulsive effects of PTZ. Since at the molecular level, a generally accepted mechanism of PTZ is noncompetitive antagonization of the GABA A receptor complex, combination of two drugs must have reversed antagonizing effect of PTZ on GABA A receptor. As diazepam efficacy in this context was not high enough at administered concentration, the extra stimulatory effect on GABA A receptor must have been compensated by ZMEO 53 . Furthermore, since ZMEO at high doses could increase threshold of PTZ induced seizure, it must have at least partly reversed antagonizing activity of PTZ on GABA A . (2) Administration of flumazenil completely antagonized both components effects. As the only known mechanism of flumazenil is ligation to GABA A receptor, ZMEO MUST have modulated the GABA A receptor activity. (3) Similar protective effects can also be observed by survival analysis represented in figure 4 .
Synthesized from its precursor L-arginine through the action of NOS enzyme, NO is a gaseous free radical which functions as a neurotransmitter modulating agent and neural messenger in CNS 54 . NO is considered as an endogenously expressed anti-convulsant agent since inhibition of its synthesis through administration of NOS inhibitors has shown to be together with exacerbation of seizures in experimentally induced rat models of seizure 55, 56 . Consistently, administration of L-arginine at concentrations high enough to increase NO levels could reverse proconvulsive effects of NOS inhibitors. In addition, administration of L-arginine could prevent rodents against sound and picrotoxin proconvulsive effects 57, 58 . Marangoz et al. demonstrated that administration of an NO donor, sodium nitroprusside, could reverse epileptiform discharges induced by intracortical administration of penicillin in rats 59 . Administration of L-arginine at concentrations high enough for increasing NO levels has shown to indirectly increase GABA levels through inhibiting the function of GABA transaminase (GABA-T), a specific enzyme involved in metabolization of GABA [60] [61] [62] . In addition, NO is capable of increasing the secretion of GABA from different regions of brain including cortex, striatum and hippocampus [63] [64] [65] . In addition, increased NO and GABA levels through the action of L-arginine could protect rats from picrotoxin induced seizure 58 Based on obtained data, it can be hypothesized that ZMEO pretreatment might have enhanced production of NO and this upregulation in CNS levels of NO was enough for protecting against proconvulsive effects of gradually increasing concentration of PTZ. This happens because synthesized NO increases GABA concentration through enhancing its secretion from different compartments of CNS and decreasing its
This article is protected by copyright. All rights reserved metabolism by inhibiting GABA-T. Due to the unique form of administration (IV infusion), initial concentration of PTZ in mouse body is very low and will be increased with a slow rate. Therefore, the amount of PTZ will not be high enough to promote secretion of adequate volume of glutamate required for activating NMDARs and inducing production of pro-convulsive concentrations of NO. Instead, enhanced level of GABA at site of action (GABA A receptor) compensates non-competitive antagonizing effect of PTZ. This hypothesis is highly strengthen considering the fact that administration of L-arginine, a precursor of NO, at concentration not enough to significantly affect clonic seizure threshold, could significantly enhance anticonvulsant effects of ZMEO at both sub-maximal and maximal concentrations. Furthermore, pretreating mice with both of the NOS inhibitors of present study, namely L-NAME and aminoguanidine, with concentrations not enough to significantly affect clonic seizure threshold, could completely reverse anti-convulsant effects observed with administration of ZEO.
Conclusion
Based on the data obtained from present study, the essential oil obtained from leaves of Zumeria majdae, could 
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Study Highlights
 What is the current knowledge on the topic?
The essential oil derived from leaves of Zhumeria majdae Rech. (ZMEO), has recently been shown to have several beneficial effects in clinical practice. However, little is known about ZMEO's potential anticonvulsant activity and its underlying pharmacological mechanism of action.
 What question did this study address?
Dose the ZMEO demonstrate significant anticonvulsant activity in the experimental models of seizure? and is this anticonvulsant activity linked to the activation of GABA A receptor or nitric oxide pathway?
 What does this study add to our knowledge?
With linalool as its most abundant component, ZMEO demonstrated a meaningful anti-convulsant activity in both IV and IP pentylenetetrazol induced mouse models of seizure. ZMEO however, was not effective in maximal electroshock model. These effects were partly mediated through activation of GABA A receptor and NO synthesis.
 How might this change clinical pharmacology or translational science?
Our data represents ZMEO as a novel anti-epileptic agent, especially for application in treatment of myoclonic/generalized absence epilepsy which is usually refractory to treatment. Furthermore, understanding the underlying mechanism of ZMEO's anticonvulsant activity will help physicians to rationally apply it as a complementary component in combinational therapies for achieving a more successful plan in treatment of resistant epilepsies. Camphor has also been provided in scheme. Table 2 -Protective effects of ZMEO and phenytoin on maximal electroshock (MES)-induced seizures in mice.
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Data represents the percentage of mice (n=10) producing THLE and mortality. 
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